---
title: "Doxepin - Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db01142-mesh-d003866-1.html
toc: false 
---


Path ID: `DB01142_MESH_D003866_1`
{% include image.html url="images/db01142-mesh-d003866-1.png" file="db01142-mesh-d003866-1.png" alt="db01142-mesh-d003866-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D004316 | doxepin | Drug |
| UniProt:P31645 | Sodium-dependent serotonin transporter | Protein |
| UniProt:P23975 | Sodium-dependent noradrenaline transporter | Protein |
| GO:0051610 | Serotonin uptake | BiologicalProcess |
| MESH:D012701 | Serotonin | ChemicalSubstance |
| GO:0051620 | Noradrenaline uptake | BiologicalProcess |
| MESH:D009638 | Noradrenaline | ChemicalSubstance |
| GO:0061533 | Norepinephrine secretion, neurotransmission | BiologicalProcess |
| GO:0060096 | Serotonin secretion, neurotransmission | BiologicalProcess |
| MESH:D003866 | Depressive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Doxepin | DECREASES ACTIVITY OF | Sodium-Dependent Serotonin Transporter |
| Doxepin | DECREASES ACTIVITY OF | Sodium-Dependent Noradrenaline Transporter |
| Sodium-Dependent Serotonin Transporter | PARTICIPATES IN | Serotonin Uptake |
| Sodium-Dependent Noradrenaline Transporter | PARTICIPATES IN | Noradrenaline Uptake |
| Noradrenaline Uptake | DECREASES ABUNDANCE OF | Noradrenaline |
| Serotonin Uptake | DECREASES ABUNDANCE OF | Serotonin |
| Serotonin | POSITIVELY CORRELATED WITH | Serotonin Secretion, Neurotransmission |
| Noradrenaline | POSITIVELY CORRELATED WITH | Norepinephrine Secretion, Neurotransmission |
| Serotonin Secretion, Neurotransmission | NEGATIVELY REGULATES | Depressive Disorder |
| Norepinephrine Secretion, Neurotransmission | NEGATIVELY REGULATES | Depressive Disorder |
|---------|-----------|---------|

Comment: Oral doxepin is approved for the depression and/or anxiety, psychotic depressive disorders with associated anxiety and insomnia. The inhibition of norepinephrine and serotonin at synaptic nerve terminals by doxepin is beleived to be MoA

Reference: 
  - [https://go.drugbank.com/drugs/DB01142](https://go.drugbank.com/drugs/DB01142)
  - [https://en.wikipedia.org/wiki/Doxepin](https://en.wikipedia.org/wiki/Doxepin)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/)
